P2Y Receptor

Cat. No.	Product name	CAS No.	Purity
T12530	PPTN	1160271-30-6	98%
T12530	PPTN is a high-affinity, competitive and highly selective antagonist of P2Y14 receptor(KB value of 434 pM), with anti-inflammatory and immune activity.
T23164	PIT	56583-49-4	98%
T23164	PIT is a specific and non-competitive antagonist of the Purinergic receptor P2Y1 with an IC50 of 0.14 μM for human P2Y1. PIT does not affect nucleotide binding a...
T63534	PPTN hydrochloride	1992047-65-0	98%
T63534	PPTN hydrochloride is a potent, high-affinity, competitive, highly selective P2Y14 receptor antagonist (KB: 434 pM), but no agonist or antagonist activity at P2Y...
T6172	MRS 2578	711019-86-2	100%
T6172	MRS2578, an effective P2Y6 receptor antagonist with IC50 of 37 nM, shows insignificant inhibition at P2Y1, P2Y2, P2Y4, and P2Y11 receptors.
T5036	Cangrelor tetrasodium	163706-36-3	100%
T5036	Cangrelor tetrasodium is a reversible and selective antagonist of platelet P2Y12, with prompt and potent antiplatelet effects.
T0179	Ticagrelor	274693-27-5	100%
T0179	Ticagrelor, produced by AstraZeneca, is an inhibitor of platelet aggregation. Unlike clopidogrel, ticagrelor is not a prodrug required metabolic activation. The ...
T8582	1-[(5-methylisoxazol-3-yl)methyl]piperazine	173850-51-6	95%
T8582	Piperazine, 1-[(5-methyl-3-isoxazolyl)methyl]- (9CI) is a P2Y12 inhibitor.
T11177	Elinogrel	936500-94-6	97.09%
T11177	Elinogrel is a competitive and reversible antagonist of platelet P2Y12 with IC50 of 20 nM and exhibits potent antiplatelet effects.
T0182	Clopidogrel	113665-84-2	98.47%
T0182	Clopidogrel, a P2Y12 receptor antagonist, decreases platelet aggregation.
T4706	Uridine-5'-diphosphate disodium salt	27821-45-0	98.6%
T4706	UDP is a specific agonist of the P2Y6 receptors (EC50 = 13 nM for human P2Y6), stimulating the production of inflammatory mediators, phagocytosis, and vasoconstr...
T21059	Ticagrelor metabolite M5	1251765-07-7	99.09%
T21059	Ticagrelor metabolite M5 is a metabolite of Ticagrelor, the first reversible oral antagonist of P2Y12 receptor. Compared to Clopidogrel, Ticagrelor has faster an...
T12164	N6-(4-Hydroxybenzyl)adenosine	110505-75-4	99.44%
T12164	N6-(4-Hydroxybenzyl)adenosine is a platelet aggregation inhibitor.
T4132	BPTU	870544-59-5	99.5%
T4132	Allosteric antagonist of P2Y1 (EC50 = 0.06-0.3 μM). Non-nucleotide ligand. Binds receptor outside of the helical bundle. Blocks inhibition of spontaneous contrac...
T0182L	Clopidogrel hydrogen sulfate	120202-66-6	99.51%
T0182L	(S)-(+)-Clopidogrel hydrogensulfate, a selective, high-affinity P2Y12 receptor antagonist, suppressess fibrinogen binding to platelets and platelet adhesion and ...
T0182L2	(±) Clopidogrel hydrogen sulfate	135046-48-9	99.62%
T0182L2	Clopidogrel, an antiplatelet agent pharmacologically and structurally analogous to ticlopidine, is used to inhibit blood clots in various conditions such as cere...
T3536	AZD1283	919351-41-0	99.621%
T3536	AZD1283 is an effective P2Y12 receptor antagonist (EC50: 3.0 ug/kg/min, binding IC50: 11 nM). AZD1283 dose-dependently induced increases in blood flow and inhibi...
T7423	Diquafosol tetrasodium	211427-08-6	99.68%
T7423	Diquafosol Tetrasodium is a P2Y2 receptor agonist that stimulates the secretion of mucins from ocular tissues Diquafosol tetrasodium improves tear film stability...
T0230	Prasugrel	150322-43-3	99.76%
T0230	Prasugrel is a piperazine derivative and PLATELET AGGREGATION INHIBITOR that is used to prevent THROMBOSIS in patients with ACUTE CORONARY SYNDROME; UNSTABLE ANG...
T6952	Prasugrel Hydrochloride	389574-19-0	99.79%
T6952	Prasugrel hydrochloride is a piperazine derivative and pletelet aggregation inhibitor that is used to prevent thrombosis in patients with acute coronary syndrome...
T4743	Uridine 5′-diphosphoglucose disodium salt	28053-08-9	99.83%
T4743	UDP-Glucose sodium salt is an endogenous nucleotide sugar involved in glycosyltransferase reactions in metabolism. It is an agonist of the P2Y14 receptor (EC50 =...